Biolog Overview

  • Year Founded
  • 1984

Year Founded

  • Status
  • Private

  • Employees
  • 110

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $16.1M

  • Investors
  • 7

Biolog General Information

Description

Developer of cell analysis tools designed to identify cell phenotypes for early-stage detection of diseases. The company offers a range of cellular analysis instruments, identification microplates, metabolic and community analysis panels, laboratory testing services, and specialized reagents and software, enabling quality control teams to perform detailed biological characterization and make informed decisions based on empirical data.

Contact Information

Website
www.biolog.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 21124 Cabot Boulevard
  • Hayward, CA 94545
  • United States
+1 (510)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 21124 Cabot Boulevard
  • Hayward, CA 94545
  • United States
+1 (510)

Biolog Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolog Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 10-Feb-2025 $16.1M Completed Generating Revenue
3. Later Stage VC (Series A) 06-Feb-2023 Completed Generating Revenue
2. Debt - PPP 29-Apr-2020 $624K Completed Generating Revenue
1. Grant 01-Jan-2005 $5.78M Completed Generating Revenue
To view Biolog’s complete valuation and funding history, request access »

Biolog Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A-1
To view Biolog’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biolog Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell analysis tools designed to identify cell phenotypes for early-stage detection of diseases. The company
Other Pharmaceuticals and Biotechnology
Hayward, CA
110 As of 2022

San Diego, CA
 

Seraing, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biolog Competitors (24)

One of Biolog’s 24 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
Diagenode Formerly VC-backed Seraing, Belgium
Creative Biolabs Corporation Shirley, NY
Harvard Bioscience Formerly PE-Backed Holliston, MA
Phenomenex Corporate Backed or Acquired Torrance, CA
You’re viewing 5 of 24 competitors. Get the full list »

Biolog Patents

Biolog Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2958429-A2 Compositions and methods to inactivate and/or reduce production of microbial toxins Inactive 20-Feb-2013
EP-2958429-A4 Compositions and methods to inactivate and/or reduce production of microbial toxins Inactive 20-Feb-2013
US-20150374786-A1 Compositions and methods to inactivate and/or reduce production of microbial toxins Active 20-Feb-2013
US-9662372-B2 Compositions and methods to inactivate and/or reduce production of microbial toxins Active 20-Feb-2013
WO-2014130655-A2 Compositions and methods to inactivate and/or reduce production of microbial toxins Inactive 20-Feb-2013 A61K38/17
To view Biolog’s complete patent history, request access »

Biolog Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolog Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
JPMorgan Life Sciences Private Capital Venture Capital Minority
BroadOak Capital Partners Growth/Expansion Minority
Research Corporation Technologies Venture Capital Minority
National Cancer Institute Government
National Institute Of Allergy and Infectious Diseases Government
You’re viewing 5 of 7 investors. Get the full list »

Biolog Acquisitions (2)

Biolog’s most recent deal was a Merger/Acquisition with Anaerobe Systems. The deal was made on 12-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Anaerobe Systems 12-Feb-2025 Merger/Acquisition Medical Supplies
MIDI Labs 04-Jan-2023 Merger/Acquisition Laboratory Services (Healthcare)
To view Biolog’s complete acquisitions history, request access »

Biolog Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Anaerobe Systems Morgan Hill, CA 1978

Biolog FAQs

  • When was Biolog founded?

    Biolog was founded in 1984.

  • Where is Biolog headquartered?

    Biolog is headquartered in Hayward, CA.

  • What is the size of Biolog?

    Biolog has 110 total employees.

  • What industry is Biolog in?

    Biolog’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Biolog a private or public company?

    Biolog is a Private company.

  • What is the current valuation of Biolog?

    The current valuation of Biolog is .

  • What is Biolog’s current revenue?

    The current revenue for Biolog is .

  • How much funding has Biolog raised over time?

    Biolog has raised $33.6M.

  • Who are Biolog’s investors?

    JPMorgan Life Sciences Private Capital, BroadOak Capital Partners, Research Corporation Technologies, National Cancer Institute, and National Institute Of Allergy and Infectious Diseases are 5 of 7 investors who have invested in Biolog.

  • Who are Biolog’s competitors?

    Illumina, Diagenode, Creative Biolabs, Harvard Bioscience, and Phenomenex are some of the 24 competitors of Biolog.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process